(Q34741227)

4 August 2017

Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings (English)

1 reference

4 August 2017

Blumer D

1

1 reference

4 August 2017

1 July 1997

1 reference

4 August 2017

Comprehensive Psychiatry

1 reference

4 August 2017

38

1 reference

4 August 2017

4

1 reference

4 August 2017

193-201

1 reference

Catatonia. I. Rating scale and standardized examination.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Schizophrenic symptoms and cerebral pathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Observations on schizophrenic stereotypies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Negative v positive schizophrenia. Definition and validation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Where have all the catatonics gone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Another view of schizophrenia subtypes. A report from the international pilot study of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Catatonia. Prevalence and importance in the manic phase of manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Catatonia: the tension insanity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Neuroleptic Malignant Syndrome and Neuroleptic-Induced Catatonia: Differential Diagnosis and Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Neuroleptic catatonia and its relationship to psychogenic catatonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Neuroleptic malignant syndrome in a case of post-partum psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Catatonia and the neuroleptic malignant syndrome--a single entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Catatonic reactions to high-potency neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

A strategy for developing novel drugs for the treatment of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Catatonia. A prospective clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

7 January 2021

The catatonic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Overview: clinical applications of the Amytal interview in psychiatric emergency settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Carbamazepine in the treatment of catatonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Management of catatonic stupor with L-dopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

7 January 2021

Diazepam for catatonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Lorazepam for psychogenic catatonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Treatment of catatonia with low-dose lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Catatonia. II. Treatment with lorazepam and electroconvulsive therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Frequency and presentation of neuroleptic malignant syndrome: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Neuroleptic malignant syndrome and catatonia: one entity or two?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

Perinatal distress and infectious disease as risk factors for catatonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2897%2990027-4

10.1016/S0010-440X(97)90027-4

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

9202876